Heart transplant in India: Lessons learned

Introduction: Heart Transplant in India started in 1994. We were initially doing 1-2 per year but the numbers have picked up since 2014 and we have done 25 in the past 3 years. We describe our experience of the last 4 years in this paper. Results: Initially, we experienced a relatively higher rate o...

Full description

Bibliographic Details
Main Authors: Balram Airan, Sarvesh Pal Singh, Sandeep Seth, Milind Padmakar Hote, Manoj Kumar Sahu, Palleti Rajashekar, Velayoudham Devagourou, Sambhunath Das, Neeraj Parakh, Ruma Ray, Sudheer Arava
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
Online Access:http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=2;spage=94;epage=99;aulast=Airan
_version_ 1811239452803072000
author Balram Airan
Sarvesh Pal Singh
Sandeep Seth
Milind Padmakar Hote
Manoj Kumar Sahu
Palleti Rajashekar
Velayoudham Devagourou
Sambhunath Das
Neeraj Parakh
Ruma Ray
Sudheer Arava
author_facet Balram Airan
Sarvesh Pal Singh
Sandeep Seth
Milind Padmakar Hote
Manoj Kumar Sahu
Palleti Rajashekar
Velayoudham Devagourou
Sambhunath Das
Neeraj Parakh
Ruma Ray
Sudheer Arava
author_sort Balram Airan
collection DOAJ
description Introduction: Heart Transplant in India started in 1994. We were initially doing 1-2 per year but the numbers have picked up since 2014 and we have done 25 in the past 3 years. We describe our experience of the last 4 years in this paper. Results: Initially, we experienced a relatively higher rate of rejections, fungal infections and graft failure. As we changed protocols, stopped using induction therapy except in high risk, maintained higher levels of immune suppression and tapered steroids faster in the first year, the complications reduced. All patients who had rejections and all the later transplants were maintained on a regime of tacrolimus, mycophenolate mofetil and steroids along with six months of valgancyclovir, voriconazole and co-trimoxazole. Steroids were tapered by six months to 0.1 mg/kg per day in all patients. Conclusions: In our recent patients, infection was the most common adverse event followed by rejection and PGD. In the latter half of our experience, we found that the complications reduced, suggesting that experience leads to less complications.
first_indexed 2024-04-12T13:00:02Z
format Article
id doaj.art-5d0a943e40bc42eeb059bb791fd9d72f
institution Directory Open Access Journal
issn 2395-5414
2454-2830
language English
last_indexed 2024-04-12T13:00:02Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of the Practice of Cardiovascular Sciences
spelling doaj.art-5d0a943e40bc42eeb059bb791fd9d72f2022-12-22T03:32:10ZengWolters Kluwer Medknow PublicationsJournal of the Practice of Cardiovascular Sciences2395-54142454-28302017-01-0132949910.4103/jpcs.jpcs_25_17Heart transplant in India: Lessons learnedBalram AiranSarvesh Pal SinghSandeep SethMilind Padmakar HoteManoj Kumar SahuPalleti RajashekarVelayoudham DevagourouSambhunath DasNeeraj ParakhRuma RaySudheer AravaIntroduction: Heart Transplant in India started in 1994. We were initially doing 1-2 per year but the numbers have picked up since 2014 and we have done 25 in the past 3 years. We describe our experience of the last 4 years in this paper. Results: Initially, we experienced a relatively higher rate of rejections, fungal infections and graft failure. As we changed protocols, stopped using induction therapy except in high risk, maintained higher levels of immune suppression and tapered steroids faster in the first year, the complications reduced. All patients who had rejections and all the later transplants were maintained on a regime of tacrolimus, mycophenolate mofetil and steroids along with six months of valgancyclovir, voriconazole and co-trimoxazole. Steroids were tapered by six months to 0.1 mg/kg per day in all patients. Conclusions: In our recent patients, infection was the most common adverse event followed by rejection and PGD. In the latter half of our experience, we found that the complications reduced, suggesting that experience leads to less complications.http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=2;spage=94;epage=99;aulast=AiranHeartIndiatransplantAIIMS
spellingShingle Balram Airan
Sarvesh Pal Singh
Sandeep Seth
Milind Padmakar Hote
Manoj Kumar Sahu
Palleti Rajashekar
Velayoudham Devagourou
Sambhunath Das
Neeraj Parakh
Ruma Ray
Sudheer Arava
Heart transplant in India: Lessons learned
Journal of the Practice of Cardiovascular Sciences
Heart
India
transplant
AIIMS
title Heart transplant in India: Lessons learned
title_full Heart transplant in India: Lessons learned
title_fullStr Heart transplant in India: Lessons learned
title_full_unstemmed Heart transplant in India: Lessons learned
title_short Heart transplant in India: Lessons learned
title_sort heart transplant in india lessons learned
topic Heart
India
transplant
AIIMS
url http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=2;spage=94;epage=99;aulast=Airan
work_keys_str_mv AT balramairan hearttransplantinindialessonslearned
AT sarveshpalsingh hearttransplantinindialessonslearned
AT sandeepseth hearttransplantinindialessonslearned
AT milindpadmakarhote hearttransplantinindialessonslearned
AT manojkumarsahu hearttransplantinindialessonslearned
AT palletirajashekar hearttransplantinindialessonslearned
AT velayoudhamdevagourou hearttransplantinindialessonslearned
AT sambhunathdas hearttransplantinindialessonslearned
AT neerajparakh hearttransplantinindialessonslearned
AT rumaray hearttransplantinindialessonslearned
AT sudheerarava hearttransplantinindialessonslearned